An Individualized-health eLibrary App for People With Multiple Sclerosis
SavvyHealth
2 other identifiers
interventional
60
1 country
1
Brief Summary
The purpose of this study is to assess the effectiveness after using a new individualized-health e-library app named SavvyHealth among people with multiple sclerosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable multiple-sclerosis
Started Oct 2021
Longer than P75 for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 25, 2021
CompletedFirst Submitted
Initial submission to the registry
October 26, 2021
CompletedFirst Posted
Study publicly available on registry
November 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
August 24, 2025
August 1, 2025
5.2 years
October 26, 2021
August 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MS Self-management Scale
A self-reported 5-point scale, five factors: healthcare provider relationship and communication, treatment adherence, social support, MS knowledge, and health maintenance behavior. "Change" is being assessed.
Through study completion, an average of 1 week
Study Arms (2)
SavvyHealth
EXPERIMENTALParticipants will use the new app, SavvyHealth, for 21 days.
Waiting list
NO INTERVENTIONParticipants will be on the waiting list.
Interventions
Eligibility Criteria
You may qualify if:
- diagnosed with MS;
- years or older;
- one comorbidity evaluated by a validated comorbidity questionnaire for people with MS;
- willing to take a survey;
- willing to use the app for 21 days;
- willing to be assigned to either the intervention or control group.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Illinois Urbana-Champaign
Champaign, Illinois, 61820, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chungyi Chiu
University of Illinois at Urbana-Champaign
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 26, 2021
First Posted
November 18, 2021
Study Start
October 25, 2021
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
August 24, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
Study result report